Western Blotting Industry

The global western blotting market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Gather more insights about the market drivers, restrains and growth of the Global Western Blotting market

Western Blotting Market Segments Highlights:

  • The consumables segment dominated the market with a share of 68.1% in 2023. The consumables segment witnessed a significant demand based on the augmented sensitivity, efficiency, and specificity of the western blotting method.
  • The disease diagnostics segment dominated the western blotting market with a revenue share of 60.4% in 2023. The growing incidences of Factor V, Herplex Symptoms Virus (HSV), Hepatitis B Virus (HBV), and Lyme sickness, incidences of chronic diseases such as cancers, and autoimmune disorders account for segment growth.
  • The pharmaceutical and biotechnology companies segment dominated the market with a revenue share of 32.0% in 2023. The growing focus on targeted treatment, personalized medicine, and increasing investment in drug discovery contribute to the segment growth.
  • North America western blotting market dominated the global market with a revenue share of 41.8% in 2023. The presence of manufacturing companies in the region, growing investment in proteomics studies, and a growing awareness of customized medicine encourage growth.

Western Blotting Market Report Segmentation

Grand View Research has segmented the global western blotting market on the basis of on type, application, end-use, and region:

Western Blotting Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments       
    • Gel Electrophoresis Instruments
    • Blotting Systems
      • Semi-dry Blotting Instruments
      • Wet Blotting Instruments
      • Imagers             
    • Chemiluminescent Imagers
      • Fluorescent Imagers
      • Others
    • Consumables     
      • Reagents and Buffers     
      • Antibodies And Conjugates         
        • Primary Antibodies
        • Secondary Antibodies
        • Other Antibodies and Conjugates
      • Kits
      • Membranes and Filters
      • Other Consumables

Western Blotting Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Biomedical & Biochemical Research        
  • Disease Diagnostics        
    • HIV
    • Lyme Disease
    • Hepatitis
    • Other Diseases
  • Agriculture
  • Others

Western Blotting End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Centers
  • Others

Western Blotting Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Key Western Blotting Company Insights

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • LI-COR, Inc.
  • Merck KGaA
  • Hoffmann-La Roche Ltd
  • Bio-Techne
  • GE HealthCare
  • PerkinElmer Inc.
  • Advansta Inc.
  • Cell Signaling Technology, Inc.

Order a free sample PDF of the Western Blotting Market Intelligence Study, published by Grand View Research.